| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.079 | 0.04 |